|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 384.45 INR | -0.85% |
|
-4.53% | +23.86% |
| 05-27 | SMS Pharmaceuticals Limited, Q4 2026 Earnings Call, May 27, 2026 | |
| 05-22 | SMS Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 35.11B 364M 319M 295M 271M 512M 520M 3.53B 1.38B 17.18B 1.37B 1.34B 59.18B | P/E 2024 |
30.3x | P/E 2025 | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.8B 392M 344M 318M 292M 551M 560M 3.8B 1.49B 18.49B 1.47B 1.44B 63.72B | EV / Sales 2024 |
2.47x | EV / Sales 2025 | 2.75x |
| Free-Float |
23.47% | Yield 2024 |
0.22% | Yield 2025 | 0.19% |
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | -0.85% | ||
| 1 week | -4.53% | ||
| Current month | -6.81% | ||
| 1 month | +1.55% | ||
| 3 months | -10.38% | ||
| 6 months | +22.32% | ||
| Current year | +23.86% |
| 1 week | 380.8 |  | 410.5 |
| 1 month | 372.45 | | 438.3 |
| Current year | 293.15 | | 447.8 |
| 1 year | 207.99 | | 447.8 |
| 3 years | 108.1 | | 447.8 |
| 5 years | 54.55 | | 447.8 |
| 10 years | 24 | | 447.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 30/08/1990 | |
| Director of Finance/CFO | - | 13/09/2017 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 30/08/1990 | |
| Director/Board Member | 37 | 05/06/2020 | |
| Director/Board Member | 48 | 29/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | -4.53% | +52.83% | +240.22% | 377M | |
| +1.23% | +1.08% | +15.52% | +80.84% | 48.15B | |
| +1.59% | +2.42% | +71.87% | +116.28% | 35.59B | |
| +1.61% | +0.15% | -2.75% | +39.18% | 11.9B | |
| +0.46% | -0.16% | +17.85% | +89.14% | 11.85B | |
| -0.37% | +2.49% | +34.42% | +136.73% | 9.31B | |
| +0.41% | +1.58% | +54.19% | -3.67% | 7.02B | |
| -0.42% | -1.32% | +16.96% | +35.57% | 6.91B | |
| -.--% | +0.14% | - | - | 6.79B | |
| +0.18% | -1.90% | +0.63% | +211.00% | 6.55B | |
| Average | +0.44% | -0.96% | +29.06% | +105.03% | 14.44B | |
| Weighted average by Cap. | +1.07% | -0.71% | +31.43% | +90.94% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.09B 73.55M 64.47M 59.59M 54.81M 103M 105M 713M 279M 3.47B 276M 270M 11.96B | 7.83B 81.17M 71.15M 65.76M 60.48M 114M 116M 786M 308M 3.83B 305M 298M 13.2B |
| Net income | 498M 5.17M 4.53M 4.19M 3.85M 7.26M 7.38M 50.06M 19.62M 244M 19.4M 18.98M 840M | 691M 7.17M 6.28M 5.81M 5.34M 10.08M 10.24M 69.46M 27.23M 338M 26.92M 26.33M 1.17B |
| Net Debt | 2.45B 25.37M 22.24M 20.56M 18.9M 35.67M 36.24M 246M 96.35M 1.2B 95.27M 93.19M 4.12B | 2.69B 27.92M 24.47M 22.62M 20.81M 39.26M 39.89M 271M 106M 1.32B 105M 103M 4.54B |
Employees
1,470
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | ₹384.45 | -0.85% | 60,828 |
| 17/07/26 | ₹387.75 | +0.17% | 119,883 |
| 16/07/26 | ₹387.10 | -1.36% | 139,223 |
| 15/07/26 | ₹392.45 | -1.70% | 128,764 |
| 14/07/26 | ₹399.25 | -0.14% | 411,138 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SMSPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
